BR0009558A - Composto derivado bicìclico heteroaromático, composição farmacêutica, e, uso de compostos derivados bicìclicos heteroaromáticos - Google Patents

Composto derivado bicìclico heteroaromático, composição farmacêutica, e, uso de compostos derivados bicìclicos heteroaromáticos

Info

Publication number
BR0009558A
BR0009558A BR0009558-3A BR0009558A BR0009558A BR 0009558 A BR0009558 A BR 0009558A BR 0009558 A BR0009558 A BR 0009558A BR 0009558 A BR0009558 A BR 0009558A
Authority
BR
Brazil
Prior art keywords
alkyl
heteroaromatic bicyclic
aryl
heterocycloalkyl
heteroaryl
Prior art date
Application number
BR0009558-3A
Other languages
English (en)
Other versions
BRPI0009558B1 (pt
Inventor
Anton Egbert Peter Adang
Gerritdina Geziena Gerritsma
Nicole Corine Renee Va Straten
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR0009558A publication Critical patent/BR0009558A/pt
Publication of BRPI0009558B1 publication Critical patent/BRPI0009558B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

"COMPOSTO DERIVADO BICìCLICO HETEROAROMáTICO, COMPOSIçãO FARMACêUTICA, E, USO DE COMPOSTOS DERIVADOS BICìCLICOS HETEROAROMáTICOS". A invenção se refere a um composto derivado biciclico heteroaromático de acordo com a fórmula geral (I) ou um sal farmacêuticamente aceitável do mesmo, em que R^ 1^ é NR^ 5^ NR^ 5^, OR^ 5^ ou SR^ 5^ ou R^ 7^; R^ 7^ e R^ 6^ são escolhidos independentemente de H, (1-8C)alquila, (2-8C)alquenila, (2-8C)alquinila, (3-8C)cicloalquila), (2-7C)heterocicloalquila, alquil(1-8C)carbonila, (6-14C) arilcarbonila, (6-14C)arila ou (4-13C)heteroarila, ou R^ 5^ e R^ 6^ em conjunto são ligados em um anel (2-7C)heterocicloalquila; R^ 7^ é (3-8C)cicloalquila, (2-7C)heterocicloalquila, (6-14C)arila ou (4-13C)heteroarila, R^ 2^ é (1-8C)alquila, (2-8C)alquenila, (2-8C) alquinila, ou (6-14C)arila ou (4-13C)heteroarila, ambos opcionalmente substituídos por um ou mais substituíntes escolhidos de (1-8C)alquila, (1-8C)alquiltio, (1-8C)(di)alquilamino, (1-8C) alcoxila, (2-8C)alquenila, ou (2-8C)alquinila; R3 é (1-8C)alquila, (2-8C) alquenila, (2-8C)alquinila, (3-8C)cicloalquila, (2-7C) heterocicloalquila, ou (6-14C)arila ou (4-13C)heteroarila, ambos opcionalmente substituídos por um ou mais substituintes escolhidos de (1-8C)(alquila), (1-8C)(di)alquilamino ou (1-8C)alcoxila; X é S, O ou N (R^ 4^); R^ 4^ é H, (1-8C)alquila, (1-8C)alquilcarbonila, (6-14C) arilcarbonila ou (6-14C)aril(1-8C)alquila; Y é CH ou N; Z é NH2 OU OH; A é S, N(H), N(W), O ou uma ligação; W pode ser escolhido dos mesmos grupos descritos para R2 e B é N(H), O ou urna ligação. Os compostos da invenção têm atividade de ativação do receptor de LH e podem ser utilizados em terapias de controle de fertilidade.
BRPI0009558A 1999-04-08 2000-04-03 composto derivado bicíclico heteroaromático ou um sal farmaceuticamente aceitável do mesmo, seu uso, e composição farmacêutica BRPI0009558B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99201152 1999-04-08
PCT/EP2000/002865 WO2000061586A1 (en) 1999-04-08 2000-04-03 Bicyclic heteroaromatic compounds useful as lh agonists

Publications (2)

Publication Number Publication Date
BR0009558A true BR0009558A (pt) 2002-02-19
BRPI0009558B1 BRPI0009558B1 (pt) 2016-10-25

Family

ID=8240094

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0009558A BRPI0009558B1 (pt) 1999-04-08 2000-04-03 composto derivado bicíclico heteroaromático ou um sal farmaceuticamente aceitável do mesmo, seu uso, e composição farmacêutica

Country Status (30)

Country Link
US (2) US6569863B1 (pt)
EP (1) EP1171443B1 (pt)
JP (1) JP4854856B2 (pt)
KR (1) KR100691546B1 (pt)
CN (1) CN1177848C (pt)
AR (1) AR028474A1 (pt)
AT (1) ATE299507T1 (pt)
AU (1) AU772258B2 (pt)
BR (1) BRPI0009558B1 (pt)
CA (1) CA2368834C (pt)
CO (1) CO5160348A1 (pt)
CZ (1) CZ300832B6 (pt)
DE (1) DE60021262T2 (pt)
DK (1) DK1171443T3 (pt)
ES (1) ES2245304T3 (pt)
HK (1) HK1041266B (pt)
HU (1) HU229002B1 (pt)
ID (1) ID30502A (pt)
IL (2) IL145483A0 (pt)
MX (1) MXPA01010144A (pt)
NO (1) NO328826B1 (pt)
NZ (1) NZ514445A (pt)
PE (1) PE20010030A1 (pt)
PL (1) PL219316B1 (pt)
PT (1) PT1171443E (pt)
RU (1) RU2248979C2 (pt)
TR (1) TR200102839T2 (pt)
TW (1) TW564247B (pt)
WO (1) WO2000061586A1 (pt)
ZA (1) ZA200107917B (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4977940B2 (ja) * 2000-09-22 2012-07-18 エム・エス・ディー・オス・ベー・フェー 二環式ヘテロ芳香族化合物
GB0100622D0 (en) 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds V111
DE10108481A1 (de) * 2001-02-22 2002-10-24 Bayer Ag Pyridylpyrimidine
PL368388A1 (en) * 2001-09-04 2005-03-21 Akzo Nobel N.V. Glycine-substituted thieno [2,3-d]pyrimidines with combined lh and fsh agonistic activity
TWI228508B (en) * 2001-09-04 2005-03-01 Akzo Nobel Nv Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity
US6974870B2 (en) 2002-06-06 2005-12-13 Boehringer Ingelheim Phamaceuticals, Inc. Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
EP1513516B1 (en) 2002-06-06 2008-12-03 Boehringer Ingelheim Pharmaceuticals Inc. SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
ATE418555T1 (de) 2003-04-09 2009-01-15 Biogen Idec Inc A2a-adenosinrezeptorantagonisten
WO2004092177A1 (en) 2003-04-09 2004-10-28 Biogen Idec Ma Inc. Triazolopyrazines and methods of making and using the same
WO2004092170A2 (en) 2003-04-09 2004-10-28 Biogen Idec Ma Inc. Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagon ists
JPWO2005019225A1 (ja) * 2003-08-21 2007-11-01 杏林製薬株式会社 Ｎｋ１受容体拮抗作用を有する化合物の製造方法及びその製造中間体
US7550485B2 (en) * 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
CA2541989C (en) * 2003-10-24 2013-10-01 Exelixis, Inc. P70s6 kinase modulators and method of use
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
NZ553329A (en) * 2004-07-22 2010-09-30 Ptc Therapeutics Inc Thienopyridines for treating hepatitis C
US8642278B2 (en) * 2005-11-22 2014-02-04 University Of South Florida Inhibition of cell proliferation
TWI417095B (zh) 2006-03-15 2013-12-01 Janssen Pharmaceuticals Inc １，４-二取代之３-氰基-吡啶酮衍生物及其作為ｍＧｌｕＲ２-受體之正向異位性調節劑之用途
JP2009537551A (ja) * 2006-05-17 2009-10-29 アメリカ合衆国 ホルモン受容体を調節するためのピリミジン低分子量リガンド
US7592353B2 (en) 2006-06-06 2009-09-22 Boehringer Ingelheim International Gmbh Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
RU2444524C2 (ru) * 2006-08-21 2012-03-10 Дженентек, Инк. Азабензотиофенильные соединения и способы применения
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
AU2008297877C1 (en) * 2007-09-14 2013-11-07 Addex Pharma S.A. 1,3-disubstituted-4-phenyl-1 H-pyridin-2-ones
CN101801951B (zh) 2007-09-14 2013-11-13 杨森制药有限公司 1’,3’-二取代的-4-苯基-3,4,5,6-四氢-2h,1’h-[1,4’]二吡啶-2’-酮
EP2200985B1 (en) 2007-09-14 2011-07-13 Ortho-McNeil-Janssen Pharmaceuticals, Inc. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
WO2009052138A1 (en) * 2007-10-18 2009-04-23 Boehringer Ingelheim International Gmbh Preparation of dihydrothieno [3, 2-d] pyrimidines and intermediates used therein
CN101861316B (zh) 2007-11-14 2013-08-21 奥梅-杨森制药有限公司 咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
ES2439291T3 (es) 2008-09-02 2014-01-22 Janssen Pharmaceuticals, Inc. Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos
JP5656848B2 (ja) 2008-10-16 2015-01-21 ジャンセン ファーマシューティカルズ， インコーポレイテッド． 代謝型グルタミン酸受容体モジュレーターとしてのインドールおよびベンゾモルホリンの誘導体
US8691813B2 (en) 2008-11-28 2014-04-08 Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
MX2011011962A (es) 2009-05-12 2012-02-28 Janssen Pharmaceuticals Inc Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostericos positivos de receptores de glutamato metabotropico (mglur2).
ME01573B (me) 2009-05-12 2014-09-20 Addex Pharma Sa DERIVATI 1,2,4-TRIAZOLO[4,3-a]PIRIDINA I NJIHOVA UPOTREBA U TRETMANU ILI PREVENCIJI NEUROLOŠKIH I PSIHIJATRIJSKIH POREMEĆAJA
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US9271967B2 (en) 2010-11-08 2016-03-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
AU2011328195B2 (en) 2010-11-08 2015-04-02 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JP5852666B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド １，２，４−トリアゾロ［４，３−ａ］ピリジン誘導体およびｍＧｌｕＲ２受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
RU2014103185A (ru) 2011-07-18 2015-08-27 Артс Байолоджикс А/С Биологически активное соединение на основе лютеинизирующего гормона (lh) с пролонгированным действием
EP3048106B1 (en) 2011-11-23 2019-11-06 Cancer Research Technology Limited Thienopyrimidine as inhibitors of atypical protein kinase c
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
KR20200036063A (ko) 2014-01-21 2020-04-06 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
PL3096790T3 (pl) 2014-01-21 2020-01-31 Janssen Pharmaceutica, N.V. Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
CN107602585A (zh) * 2017-10-23 2018-01-19 遵义医学院 噻吩并吡啶双杂环化合物的制备工艺
BR102019022529A2 (pt) * 2019-10-25 2021-05-04 Anhanguera Educacional Ltda. Processo para obtenção de composições farmacêuticas antitumorais através de butadienos push-pull, compostos e seus usos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3262593A (en) 1992-01-11 1993-08-03 Schering Agrochemicals Limited Biheterocyclic fungicidal compounds
JP3854648B2 (ja) * 1994-04-19 2006-12-06 武田薬品工業株式会社 縮合チオフェン誘導体、その製造法及び用途
TW449600B (en) 1994-04-19 2001-08-11 Takeda Chemical Industries Ltd Condensed-ring thiophene derivatives, their production and use
AU699354B2 (en) * 1994-11-08 1998-12-03 Takeda Chemical Industries Ltd. Thienopyridine or thienopyrimidine derivatives useful as anti-inflammatory agents or in the treatment of osteoporosis
JPH09169767A (ja) * 1995-10-19 1997-06-30 Takeda Chem Ind Ltd 複素環化合物、その製造法および用途
JPH09169766A (ja) * 1995-10-19 1997-06-30 Takeda Chem Ind Ltd チエノピリジン誘導体，その製造法および用途
AU7333396A (en) 1995-10-19 1997-05-07 Takeda Chemical Industries Ltd. Thienopyridine derivatives as gonadotropin releasing hormone antagonists
EP0900222A1 (en) 1996-04-26 1999-03-10 Takeda Chemical Industries, Ltd. Thienopyridine derivatives, their production and use

Also Published As

Publication number Publication date
JP2002541259A (ja) 2002-12-03
ZA200107917B (en) 2003-09-23
DK1171443T3 (da) 2005-11-07
HUP0200653A3 (en) 2004-07-28
EP1171443B1 (en) 2005-07-13
IL145483A0 (en) 2002-06-30
US20030212081A1 (en) 2003-11-13
CO5160348A1 (es) 2002-05-30
TR200102839T2 (tr) 2002-04-22
CN1349535A (zh) 2002-05-15
EP1171443A1 (en) 2002-01-16
AR028474A1 (es) 2003-05-14
CA2368834A1 (en) 2000-10-19
US6569863B1 (en) 2003-05-27
NO20014824L (no) 2001-10-04
AU772258B2 (en) 2004-04-22
PL219316B1 (pl) 2015-04-30
PL350964A1 (en) 2003-02-24
NO328826B1 (no) 2010-05-25
JP4854856B2 (ja) 2012-01-18
BRPI0009558B1 (pt) 2016-10-25
CZ300832B6 (cs) 2009-08-19
RU2248979C2 (ru) 2005-03-27
KR20010103801A (ko) 2001-11-23
AU3816600A (en) 2000-11-14
ES2245304T3 (es) 2006-01-01
NO20014824D0 (no) 2001-10-04
MXPA01010144A (es) 2002-04-24
US6841553B2 (en) 2005-01-11
PE20010030A1 (es) 2001-01-27
TW564247B (en) 2003-12-01
DE60021262D1 (de) 2005-08-18
CA2368834C (en) 2009-11-03
WO2000061586A1 (en) 2000-10-19
ID30502A (id) 2001-12-13
HK1041266A1 (en) 2002-07-05
CN1177848C (zh) 2004-12-01
HU229002B1 (en) 2013-07-29
CZ20013605A3 (cs) 2002-03-13
DE60021262T2 (de) 2006-01-05
HK1041266B (zh) 2005-09-16
IL145483A (en) 2007-06-03
KR100691546B1 (ko) 2007-03-12
ATE299507T1 (de) 2005-07-15
NZ514445A (en) 2003-07-25
PT1171443E (pt) 2005-11-30
HUP0200653A2 (en) 2002-06-29

Similar Documents

Publication Publication Date Title
BR0009558A (pt) Composto derivado bicìclico heteroaromático, composição farmacêutica, e, uso de compostos derivados bicìclicos heteroaromáticos
CA2329703A1 (en) Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
BR0010520A (pt) Novos compostos farmaceuticamente ativos
BRPI9912726A (pt) derivado de amida, composição farmacêutica, e, uso de um derivado de amida.
RS51795B (en) 2-AMINO-7,8-DIHYDRO-6H-PIRIDO [4,3-D] PYRIMIDINE-5-ONE, A PROCEDURE FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE391719T1 (de) Pyrido (2,3-d) pyrimidine und 4-amino-primidine als inhibitoren der zellulären proliferation
MXPA03011638A (es) Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6.
AR011174A1 (es) Compuestos de pirazina, composiciones farmaceuticas que los contienen, su uso en la peparacion de medicamentos y proceso para prepararlos
EP1939175A4 (en) SULFONAMIDE DERIVATIVITY WITH PGD2 RECEPTOR ANTAGONISTIC EFFECT
BRPI0209216B8 (pt) derivados de quinolina e de quinazolina, composições farmacêuticas compreendendo os mesmos e seus usos
BR9908764A (pt) Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica
BRPI0114704B8 (pt) composto de imidazol fundido a arila ou heteroarila, suas composições farmacêuticas, bem como seu uso
BR0108456A (pt) Composto, uso de um composto, métodos de tratamento ou de profilaxia de distúrbios psicóticos ou distúrbios de deterioração intelectual e de doenças humanas, e ,processo para preparação de um composto
PA8495101A1 (es) Derivados de 13-metileritromicina
HRP20110344T1 (hr) Derivati dihidropiridina
ATE286031T1 (de) Substituierte 5-benzyl-2,4-diaminopyrimidine
MXPA04005426A (es) Derivados de pirazol de anillos fuisionados.
HUP0402586A2 (hu) Azetidinszármazékot tartalmazó gyógyszerészeti készítmények
DK1165544T3 (da) Substituerede 1,4-dihydroindeno[1,2-c]pyrazoler som inhibitorer af tyrosinkinase
BR0211938A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso do dito composto ou de um sal ou solvato farmaceuticamente aceitável do mesmo, e, método para tratar os distúrbios de fertilidade em pacientes em necessidade do mesmo
HUP0400652A2 (hu) Új karbapenemszármazékok és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HRP20050617A2 (en) Imidazol derivatives having affinity for alpha 2 receptors activity
BR0212173A (pt) Derivado de tieno [2,3-d] pirimidina, composição farmacêutica, uso de compostos de tieno[2,3-d]pirimidina ou um sal ou solvato deste farmaceuticamente aceitáveis, e, método para tratamento de distúrbios de fertilidade em pacientes em necessidade do mesmo
HUP0302255A2 (hu) Szulfonamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0202438A2 (hu) Dioxo-tiazolidin-származékok és ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: C07D 495/04, A61K 31/505, C07D 487/04, A61K 31/44

Ipc: C07D 495/04 (2009.01), C07D 487/04 (2009.01), A61K

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: MSD OSS B.V. (NL)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: ORGANON BIOSCIENCES NEDERLAND B.V. (NL)

B25A Requested transfer of rights approved

Owner name: MERCK SHARP AND DOHME B.V. (NL)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 25/10/2016, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2508 DE 29-01-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.